Peritoneal dialysis role in heart failure treatment. Experience in our center;Papel de la diálisis peritoneal en el tratamiento de la insuficiencia cardíaca. Experiencia en nuestro centro

Nefrologia

Volumn 27, Issue 5, 2007, Pages 605-611

  Díez Ojea, Beatriz ^a   Rodriguez Suarez C ^b   Vidau, P ^b   Gago, E ^b   Diaz Molina B ^b   Fernández, Ma Martín ^b   Garcia Cueto C ^b  

^a HOSPITAL VALLE DEL NALÓN   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Heart failure; Hospitalization; Peritoneal dialysis

Indexed keywords

AGED; CASE REPORT; CHRONIC KIDNEY FAILURE; FEMALE; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RETROSPECTIVE STUDY; REVIEW;

AGED; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 39849103347     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Massie BM, Shah NB: Evolving trends in the epidemiologic factors of heart failure: rationale for preventative strategies and comprehensive disease. Am Heart J 133: 703-712, 1997.
2. Rodríguez-Artalejo F, Banegas Banegas JR, Guallar-Castillón P: Epidemiología de la insuficiencia cardíaca. Rev Esp Cardiol 57 (2): 163-170, 2004.
3. Portolés J, López-Gómez JM, Aljama P, Tato AM: Riesgo cardiovascular en hemodiálisis en España: prevalencia, pautas de actuación y objetivos (estudio MAR). Nefrología 25 (3): 297-306, 2005.
4. Bertoli SV, Ciurlino D, Maccario M, Martino S, Bigatti G, Traversi L, Procaccio M, Buzzi L: Home peritoneal Ultrafiltration in Patients with Severe Congestive Heart Failure Without End-Stage Renal Disease. Adv Perit Dial 21: 123-127, 2005.
5. Kagan A, Rapoport J: The role of peritoneal dialysis in the treatment of refractory heart failure. Nephrol Dial Transplant 20 (Supl. 7): vii28-vii31, 2005.
6. Mehrotra R, Kathuria P: Place of peritoneal dialysis in the management of treatment-resistant congestive heart failure. Kidney Int 70 (Supl. 103): S67-S71, 2006.
7. Cadnapaphornchai M, Gurevich AK, Weinberger HD, Schrier RW: Pathophysiology of Sodium and Water Retention in Heart Failure. Cardiology 96: 122-131, 2001.
8. Agostoni PG, Marenzi GC: Sustained Benefit from Ultrafiltration in Moderate Congestive Heart Failure. Cardiology 96: 183-189, 2001.
9. Khalifeh N, Vychytil A, Hörl WH: The role of peritoneal dialysis in the management of treatment-resistant congestive heart failure: a European perspective. Kidney Int 70 (Supl. 103): S72-S75, 2006.
10. Canaud B, Leblanc M, Leray-Moragues H, Delmas S, Klouche K, Beraud JJ: Slow continuous and daily ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 13 (Supl. 4): 51-55, 1998.
11. Swartz RD: The use of peritoneal dialysis in special situations. Adv Perit Dial 15: 160-166, 1999.
12. Cnossen N, Kooman JP, Konings CJ, Van Danzzig JM, Van der Sande FM, Leunissen K: Peritoneal dialysis in patients with congestive heart failure. Nephrol Dial Transplant 21 (Supl. 2): 63-66, 2006.
13. Schneierson JC: Continuos peritoneal irrigation in the treatment of intractable edema of cardiac origin. Am J Med Sci 218: 75-79, 1949.
14. Gotloib L, Fudin R: The impact of peritoneal dialysis upon quality of life and mortality of patients with end-satge congestive heart failure. Contrib Nephrol 150: 247-253, 2006.
15. Ryckelynk JP, Lobbedez T, Valette B, Le Goff C, Mazouz O, Levaltier B, Potier JC, Hurault de Ligny B: Peritoneal ultrafiltration and treatment-resistant heart failure. Nephrol Dial Transplant 13 (Supl. 4): 56-59, 1998.
16. Gotloib L, Fudin R, Yakubovich M, Vienken J. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 20 (Supl. 7): vii32-vii36, 2005.
17. Levey AS, Bosh JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 130 (6): 461-470, 1999.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (5): 373-383, 1987.
19. Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R: A randomiced, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafilo therapy in severe pulmonary artery hypertension. Am J Heart J 151 (4): 851.e1-5, 2006.
20. National Kidney Fundation: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification and stratification. Am J Kidney Dis 39 (Supl. 1): S1-S266, 2002.
21. Rubinger D: Management of refractory congestive heart failure-a nephrological challenge. Nephrol Dial Transplant 20 (Supl. 7): vii37-vii40, 2005.
22. Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, Horwitz RI: Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol 85 (9): 1110-1113, 2000.
23. Tobe SW, Raymond N, Ismail NA: Peritoneal Dialysis: A Clinical Update Congestive Heart Failure and PD. Contrib Nephrol 150: 129-134, 2006.
24. Mehrotra R, Khanna R: Peritoneal Ultrafiltration for Chronic Congestive Heart Failure: Rationale, Evidence and Future. Cardiology 96: 177-182, 2001.
25. Zoccali C, Mallamaci F, Benedetto FA, tripepi G, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Cottini E, Malatino LS; Creed Investigators: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12 (7): 1508-1515, 2001.
26. Elhalel-Dranitzki M, Rubinger D, Moscovici A, Haviv YS, Friedlaender MM, Silver J, Popovtzer MM: CAPD to improve quality of life in patient with refractory heart failure. Nephrol Dial Transplant 13: 3041-3042, 1998.
27. Hébert MJ, Falardeau M, Pichette V, Houde M, Nolin L, Cardinal J, Ouimet D: Continuous Ambulatory Peritoneal Dialysis for Patients With Severe Left Ventricular Systolic Dysfunction and End-Stage Renal Disease. Am J Kidney Dis 25 (5): 761-768, 1995.
28. Ortiz AM, Acosta PA, Corbalan R, Jalil JE: Long-Term Automated Peritoneal Dialysis in Patients with Refractory Congestive Heart Failure. Adv Perit Dial 19: 78-80, 2003.
29. Stegmayr BG, Banga R, Lundberg L, Wikdahl AM, Plum-Wirell M: PD treatment for severe congestive heart failure. Perit Dial Int 16 (Supl. 1): S231-S235, 1996.
30. Sheppard R, Panyon J, Pohwani AL, Macgowan G, McNamara D, Mathier M, Johnston JR, Murali S: Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 10 (5): 380-383, 2004.
31. Stack AG, Molony DA, Rahman S, Dosekun A, Murthy B: Impact of dialysis modality in survival of new ESRD patient with congestive heart failure in the United States. Kidney Int 64: 1071-1079, 2003.
32. Silverberg DS, Wexler D, Blum M, Schwartz D, Wollman Y, Iaina A: Erythropoietin should be part of congestive heart failure management. Kidney Int (Supl. 87): S40-47, 2003.
33. Cai Z, Semenza GL: Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 109 (17): 2050-2053, 2004.
34. Molina A, Montenegro J, Remón-Rodríguez C: Inicio de Diálisis Peritoneal. Indicaciones y Contraindicaciones de la Diálisis Peritoneal. p. 32. En: Guías de Práctica Clínica en Diálisis Peritoneal. Sociedad Española de Nefrología. Arrieta J, Bajo MA, Caravaca F, Coronel F, García-Pérez H, González-Parra E, Granado A, Martín-Govantes J, Miguel A, Molina A, Montenegro J, Pérez- Bañasco V, Pérez-Fontán M, Remón-Rodríguez C, Rodríguez-Palomares JR, Ruiz C, Sánchez-Moreno A, Vega N. Nefrología 26 (Supl. 4), 2005.